Similar articles

• [Value of malarone in therapy of malaria tropica].

  Ziegler T, Schau A, Winkler C. Ziegler T, et al. Med Klin (Munich). 2002 Aug 15;97(8):455-8. doi: 10.1007/s00063-002-1179-z. Med Klin (Munich). 2002. PMID: 12229244 Review. German.
• Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.

  Looareesuwan S, Chulay JD, Canfield CJ, Hutchinson DB. Looareesuwan S, et al. Am J Trop Med Hyg. 1999 Apr;60(4):533-41. doi: 10.4269/ajtmh.1999.60.533. Am J Trop Med Hyg. 1999. PMID: 10348225 Review.
• Atovaquone and proguanil for Plasmodium falciparum malaria.

  Radloff PD, Philipps J, Nkeyi M, Hutchinson D, Kremsner PG. Radloff PD, et al. Lancet. 1996 Jun 1;347(9014):1511-4. doi: 10.1016/s0140-6736(96)90671-6. Lancet. 1996. PMID: 8684102 Clinical Trial.
• Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.

  McKeage K, Scott L. McKeage K, et al. Drugs. 2003;63(6):597-623. doi: 10.2165/00003495-200363060-00006. Drugs. 2003. PMID: 12656656 Review.
• The safety of atovaquone/proguanil in long-term malaria prophylaxis of nonimmune adults.

  Petersen E. Petersen E. J Travel Med. 2003 May;10 Suppl 1:S13-5; discussion S21. doi: 10.2310/7060.2003.35050. J Travel Med. 2003. PMID: 12737755